Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)

INTRODUCTION: Glycemic control is important to avoid diabetes complications in individuals with cancer. There is no evidence for HbA1c and fructosamine as reliable biomarkers in these conditions. There are particularities in caring for patients with diabetes and cancer that can alter these biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyoshima, Marcos Tadashi Kakitani, Cukier, Priscilla, Damascena, Aline Santos, Batista, Rafael Loch, Correa, Fernanda de Azevedo, Kawahara, Eduardo Zanatta, Minanni, Carlos André, Hoff, Ana O., Nery, Marcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338289/
https://www.ncbi.nlm.nih.gov/pubmed/37390617
http://dx.doi.org/10.1016/j.clinsp.2023.100240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338289/
https://www.ncbi.nlm.nih.gov/pubmed/37390617
http://dx.doi.org/10.1016/j.clinsp.2023.100240

Ejemplares similares